RachelJoySchindlerMD

PubMed

• 37 citations
  Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force Report.
  Randall J. Bateman, Kaj Blennow, Rachelle Doody, Susan L. Hendrix, Simon Lovestone, Stephen Salloway, Rachel Schindler, M. Weiner, Henrik Zetterberg, Paul S. Aisen, Br...> ;The Journal of Prevention of Alzheimer's Disease. 2019 Jan 1
• 18 citations
  Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors.
  Kenneth Rockwood, Susan E. Howlett, Deborah Hoffman, Rachel Schindler, Arnold Mitnitski> ;Alzheimer's & Dementia. 2017 Oct 1
• 17 citations
  EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials.
  Paul S. Aisen, Jacques Touchon, Rebecca E. Amariglio, S. Andrieu, Randall J. Bateman, John C.S. Breitner, Michael C. Donohue, Billy Dunn, Rachelle Doody, Nick C. Fox, ...> ;The Journal of Prevention of Alzheimer's Disease. 2017 Jan 1
• 6 citations
  Suicidal ideation and behavior assessment in dementia studies: An Internet survey
  Phillip B. Chappell, Sarah Dubrava, Michelle Stewart, Dean M. Hartley, Larry Alphs, H. Robert Brashear, Yeates Conwell, David S. Miller, Rachel Schindler, Eric Siemers...> ;Alzheimer's & Dementia. 2016 Jan 1
• 12 citations
  Considerations for the assessment of suicidal ideation and behavior in older adults with cognitive decline and dementia
  Larry Alphs, H. Robert Brashear, Phillip B. Chappell, Yeates Conwell, Sarah Dubrava, Ni A. Khin, Nicholas Kozauer, Dean M. Hartley, David S. Miller, Rachel Schindler, ...> ;Alzheimer's & Dementia. 2016 Jan 1
• 3 citations
  Resting-State Cardiac Workload is Related to Both Increased Neocortical Aggregation of Amyloid-β and Relative Impairments in Spatial Working Memory in Pre-Clinical Alz...
  Cláudia Y. Santos, Yen Ying Lim, Wen-Chih Wu, Jason T. Machan, Shahena Polynice, Rachel Schindler, Paul Maruff, Peter J. Snyder> ;Journal of Alzheimer's Disease. 2015 Nov 27
• 51 citations
  Disruption of cholinergic neurotransmission exacerbates Aβ-related cognitive impairment in preclinical Alzheimer's disease
  Yen Ying Lim, Paul Maruff, Rachel Schindler, Brian R. Ott, Stephen Salloway, Don C. Yoo, Richard B. Noto, Cláudia Y. Santos, Peter J. Snyder> ;Neurobiology of Aging. 2015 Oct 1
• 69 citations
  Assessing cognition and function in Alzheimer's disease clinical trials: Do we have the right tools?
  Peter J. Snyder, Kristin Kahle-Wrobleski, Stephen Brannan, David S. Miller, Rachel Schindler, Susan DeSanti, J. Michael Ryan, Glenn Morrison, Michael Grundman, Julie C...> ;Alzheimer's & Dementia. 2014 Nov 1
• 56 citations
  2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease
  Keith N. Fargo, Paul S. Aisen, Marilyn S. Albert, Rhoda Au, Maria M. Corrada, Steven T. DeKosky, David A. Drachman, Howard Fillit, Laura N. Gitlin, Magali Haas, Karl H...> ;Alzheimer's & Dementia. 2014 Oct 1
• 25 citations
  Microdosing of scopolamine as a “cognitive stress test”: Rationale and test of a very low dose in an at-risk cohort of older adults
  Peter J. Snyder, Yen Ying Lim, Rachel Schindler, Brian R. Ott, Stephen Salloway, Lori A. Daiello, Christine Getter, Catherine M. Gordon, Paul Maruff> ;Alzheimer's & Dementia. 2014 Mar 1
• 36 citations
  Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria
  Maria C. Carrillo, Robert A. Dean, Francois Serge Nicolas, David Miller, Robert M. Berman, Zaven S. Khachaturian, Lisa J. Bain, Rachel Schindler, David S. Knopman> ;Alzheimer's & Dementia. 2013 Sep 1
• 1 citations
  Output of the working group on magnetic resonance imaging abnormalities and treatment with amyloid-modifying agents.
  Rachel Schindler, Howard Feldman, Maria C. Carrillo> ;Alzheimer's & Dementia. 2011 Jul 1
• 454 citations
  Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.
  Reisa A. Sperling, Clifford R. Jack, Sandra E. Black, Matthew P. Frosch, Steven M. Greenberg, Bradley T. Hyman, Philip Scheltens, Maria C. Carrillo, William Thies, Mar...> ;Alzheimer's & Dementia. 2011 Jul 1
• 11 citations
  Global issues in drug development for Alzheimer's disease
  Rachelle S. Doody, Patricia E. Cole, David S. Miller, Eric Siemers, Ronald Black, Howard Feldman, Rachel Schindler, Stephen M. Graham, Theresa Heath, Ara S. Khachaturi...> ;Alzheimer's & Dementia. 2011 Mar 1
• 127 citations
  Report of the task force on designing clinical trials in early (predementia) AD
  Paul S. Aisen, S. Andrieu, Cristina Sampaio, Maria C. Carrillo, Zaven S. Khachaturian, Bruno Dubois, Howard Feldman, Ronald C. Petersen, Eric Siemers, Rachelle S. Dood...> ;Neurology. 2011 Jan 18
• 30 citations
  Predicting cognitive decline in Alzheimer's disease: an integrated analysis.
  Oscar L. Lopez, Elias Schwam, Jeffrey L. Cummings, Serge Gauthier, Roy W. Jones, David Wilkinson, Gunhild Waldemar, Richard Zhang, Rachel Schindler> ;Alzheimer's & Dementia. 2010 Nov 1
• 28 citations
  Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease
  Serge Gauthier, Oscar L. Lopez, Gunhild Waldemar, Roy W. Jones, Jeffrey L. Cummings, Richard Zhang, Rachel Schindler, Elias Schwam> ;International Psychogeriatrics. 2010 Sep 1
• 87 citations
  Randomized, Placebo-Controlled, Clinical Trial of Donepezil in Vascular Dementia Differential Effects by Hippocampal Size
  Gustavo C. Román, Stephen Salloway, Sandra E. Black, Donald R. Royall, Charles DeCarli, Michael Weiner, Margaret Moline, Dinesh Kumar, Rachel Schindler, Holly Posner> ;Stroke. 2010 Jun 1
• 283 citations
  Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease LEADe
  Howard Feldman, Rachelle S. Doody, Miia Kivipelto, D L Sparks, David D. Waters, Roy W. Jones, Elias Schwam, Rachel Schindler, Judith Hey-Hadavi, David A. DeMicco, Andr...> ;Neurology. 2010 Mar 23
• 16 citations
  The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
  David Wilkinson, Gustavo C. Roman, Stephen Salloway, Jane Hecker, Karyn Boundy, Dinesh Kumar, Holly Posner, Rachel Schindler> ;International Journal of Geriatric Psychiatry. 2010 Mar 1
• 69 citations
  The primary care physician and Alzheimer's disease: An International position paper
  Hélène Villars, Stéphane Oustric, Sandrine Andrieu, Jean-Pierre Baeyens, Roberto Bernabei, Henry Brodaty, K. Brummel-Smith, C. Celafu, N. Chappell, Jaime Fitten, Giova...> ;The Journal of Nutrition, Health & Aging. 2010 Mar 11
• 13 citations
  Study design considerations: Conducting global clinical trials in early Alzheimer’s disease
  Rachel Schindler> ;The Journal of Nutrition, Health & Aging. 2010 Jan 30
• 17 citations
  Rates of cognitive change in Alzheimer disease: observations across a decade of placebo-controlled clinical trials with donepezil.
  Roy W. Jones, Elias Schwam, David Wilkinson, Gunhild Waldemar, Howard Feldman, J Richard Zhang, Kenneth S. Albert, Rachel Schindler> ;Alzheimer Disease and Associated Disorders. 2009 Oct 1
• 37 citations
  Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer’s Disease
  David Wilkinson, Rachel Schindler, Elias Schwam, Gunhild Waldemar, Roy W. Jones, Serge Gauthier, Oscar L. Lopez, Jeffrey L. Cummings, Yikang Xu, Howard Feldman> ;Dementia and Geriatric Cognitive Disorders. 2009 Jan 1
• 47 citations
  The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.
  Roy W. Jones, Miia Kivipelto, Howard Feldman, Larry Sparks, Rachelle S. Doody, David D. Waters, Judith Hey-Hadavi, Andrei Breazna, Rachel Schindler, Harry Ramos, LEADe...> ;Alzheimer's & Dementia. 2008 Mar 1
• Join now to see all